-
Mashup Score: 4JNCCN 360 - Non–Small Cell Lung Cancer - Phase III Trial Supports Use of Toripalimab Plus Chemotherapy in Stage III NSCLC - 2 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2JNCCN 360 - Non–Small Cell Lung Cancer - Osimertinib With Chemotherapy Granted FDA Approval for EGFR-Mutated NSCLC - 2 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2JNCCN 360 - Non–Small Cell Lung Cancer - NDR2 Expression: A Useful Biomarker in Predicting Metastatic Risk in Patients With NSCLC? - 3 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: General Medicine News, Onc News and JournalsTweet
Phase III Trial Supports Use of Toripalimab Plus Chemotherapy in Stage III #NSCLC: https://t.co/7abNhaXDcS #JNCCN360 #LCSM https://t.co/3Sw99yXxox